+13.1%
GSK vs BNS
+52.0%
-38.9%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BNS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +3.0% | +2.1% | +4.4% |
| 7D | +4.9% | +2.0% | +2.9% | +4.5% |
| 30D | +9.9% | +7.8% | +2.1% | +8.1% |
| 3M | +0.2% | +11.7% | -11.5% | -2.2% |
| 6M | +2.3% | +28.2% | -25.9% | -4.4% |
| YTD | +7.1% | +34.8% | -27.7% | -2.5% |
| 1Y | +13.1% | +51.1% | -37.9% | -2.1% |
| All | +13.1% | +52.0% | -38.9% | -2.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BNS.
Daily Out/Under-Performance
Portfolio return minus BNS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BNS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BNS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling